EquityZen Growth Technology Fund LLC - Series 1951
Raised
$110K
Investors
8
Min Invest
$9,944
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1951 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors LLC and Phil Haslett on 2024-10-30, reporting $110K raised from 8 investors under Rule 506(b) and Section 3(c)(1). The offering carries a $10K minimum investment and is part of EquityZen's platform of nearly 1,900 related EDGAR entities focused on pre-IPO secondary market access.
This pre-IPO vehicle uses the standard 506(b)/3(c)(1) exemption pattern typical of EquityZen's single-company SPV structure, with a $10K retail-accessible minimum. The raise size and investor count are consistent with early-stage or smaller secondary share blocks within the platform's deal-by-deal series model.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Phil Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.